Redskins: 3 potential partners in the event the team trades down
![JACKSONVILLE, FL - DECEMBER 30: Lamar Jackson #8 of the Louisville Cardinals takes the field prior to the TaxSlayer Bowl against the Mississippi State Bulldogs at EverBank Field on December 30, 2017 in Jacksonville, Florida. (Photo by Joe Robbins/Getty Images) JACKSONVILLE, FL - DECEMBER 30: Lamar Jackson #8 of the Louisville Cardinals takes the field prior to the TaxSlayer Bowl against the Mississippi State Bulldogs at EverBank Field on December 30, 2017 in Jacksonville, Florida. (Photo by Joe Robbins/Getty Images)](https://images2.minutemediacdn.com/image/upload/c_fill,w_720,ar_16:9,f_auto,q_auto,g_auto/shape/cover/sport/446690d2cab26c39265147119e1bd6e88154fd97e1a999609d7496103df79ab2.jpg)
Should the Redskins make a trade?
This question is an interesting one, and it has a two-pronged answer. In the event that neither Da’Ron Payne or Minkah Fitzpatrick are on the board at the 13th pick, the team will have a choice to make. They could opt for Vita Vea, if he’s available, or they could try to trade down.
The benefits of taking a nose tackle with their top pick are obvious. They would no longer have a glaring weakness on their defense, and that would do a lot to help the team defend against the run in their base defense. But, if the team can pick up enough extra value via a trade while still getting B.J. Hill in Round 2, it could be worth a move down.
The same could be said of taking a running back at 13, but the positional value would be better in a trade down. Neither Guice or Michel are worth the No. 13 pick, so trading back to get either would make more sense.
Next: Redskins Top 10 running back Big Board
It’s frankly too early to tell if trading is a sensible option for the Redskins. Once it’s better known who the top 10 picks will be, the Redskins will be able to weigh their options more. Right now, anything should be an option for the team, and if any of these trade offers become more than speculation, then the team should seriously consider them.